Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.410EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used